Mark L. Brader

Encapsulation state of messenger RNA inside lipid nanoparticles

Mark L. Brader, Sean Williams, Jessica M. Banks et al. · Biophysical Journal · 2021 · 208 citations · Full text

Nanoparticles, Nanomedicine, Proteinlipid Interaction +13

Quantitation of Aggregate Levels in a Recombinant Humanized Monoclonal Antibody Formulation by Size-Exclusion Chromatography, Asymmetrical Flow Field Flow Fractionation, and Sedimentation Velocity

John P. Gabrielson, Mark L. Brader, Allen H. Pekar et al. · Journal of Pharmaceutical Sciences · 2006 · 173 citations

Sedimentation Velocity, Aggregate Levels, Size-exclusion Chromatography +15

Examination of Thermal Unfolding and Aggregation Profiles of a Series of Developable Therapeutic Monoclonal Antibodies

Mark L. Brader, Tia Estey, Shujun Bai et al. · Molecular Pharmaceutics · 2015 · 157 citations

Immunocytochemical Technique, Engineering, Protein Phase Separation +21

Hybrid insulin cocrystals for controlled release delivery

Mark L. Brader, Muppalla Sukumar, Allen H. Pekar et al. · Nature Biotechnology · 2002 · 91 citations

Diabetes, Controlled Release Delivery, Biomedical Engineering +3

Physicochemical basis for the rapid time‐action of Lys^B28Pro^B29‐insulin: Dissociation of a protein‐ligand complex

Diane L. Bakaysa, J. Radziuk, Henry A. Havel et al. · Protein Science · 1996 · 87 citations · Full text

Protein‐ligand Complex, Chemical Biology, Insulin Signaling +18